PDS Biotechnology Corporation (PDSB)
Nasdaq: PDSB · Pharmaceutical Preparations · Princeton, NJ · filing with the SEC since 2009
Who owns PDS Biotechnology Corporation
As filed with the SECHolders of 5% or more
1
Nant Capital, LLC holds 19.9% of Common Stock, par value $0.00033 per share, as its SCHEDULE 13D filed Sep 21, 2026 says.
Directors and officers
17
report now, of 46 people on the record since 2015. Their holdings as a group are not read here.
Institutions as a whole
n/a
The record does not read the share held by managers that file Form 13F, so none is printed and no split of the rest is estimated. What it holds is the 1 named at left.
Holders of 5% or moreshare of the class, as filed
Nant Capital, LLC
SCHEDULE 13D · filed Sep 21, 2026 · Common Stock, par value $0.00033 per share
Armistice Capital, LLC
SCHEDULE 13G/A · filed Aug 14, 2025 · Common Stock, par value $0.00033 per share · reported falling below 5%, from 9.99% in May 15, 2025
What PDSB reports owning in othersstakes of 5% or more, and other ties
1 subsidiary in 1 country, from the list filed with the 10-K filed Mar 28, 2024.
Insider tradesForm 4
0sales
0purchases
0sales on a scheduled plan
0people selling
$0sold, in dollars
$0bought, in dollars
Open-market trades on Form 4 from Oct 21, 2025 to Oct 21, 2026. A scheduled plan is a selling program set in advance under SEC rule 10b5-1. The trades are listed as filed and do not feed the grade.
By calendar yearSoldBought
2025 runs to Oct 21, 2026. Dollars as filed, summed by the transaction date.
People who traded in the window
No one on the roster filed an open-market trade in the window.